Related Experiment Video

Updated: Aug 18, 2026

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature
10:07

Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tg(fli:EGFP) Zebrafish Retinal Vasculature

Published on: December 26, 2017

Pathogenesis, prevention, and treatment of diabetic nephropathy

M E Cooper1

  • 1Department of Medicine, University of Melbourne, Austin and Repatriation Medical Centre (Repatriation Campus), West Heidelberg, VIC, Australia. cooper@austin.unimelb.edu.au

Lancet (London, England)
|July 31, 1998
PubMed

Insights

Diabetic nephropathy involves both metabolic and hemodynamic factors. Targeting these pathways with specific inhibitors and managing blood pressure are key to preventing and treating this kidney disease.

Area of Science:

  • Nephrology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic nephropathy pathophysiology involves complex metabolic and hemodynamic interactions.
  • Key metabolic pathways include advanced glycation, polyol formation, and protein kinase C activation.
  • Hemodynamic factors comprise systemic and intraglomerular hypertension, and vasoactive hormones like angiotensin II.

Purpose of the Study:

  • To investigate the role of metabolic and hemodynamic factors in diabetic nephropathy pathogenesis.
  • To explore novel therapeutic strategies targeting these pathways for diabetic nephropathy prevention and treatment.

Main Methods:

  • Utilizing specific pathway inhibitors to study metabolic contributions.
  • Evaluating the impact of antihypertensive therapies, including renin-angiotensin system inhibitors.
  • Assessing the role of glycemic control and blood pressure management.

Main Results:

  • Metabolic pathways like advanced glycation and polyol formation are implicated in diabetic nephropathy.
  • Hypertension and angiotensin II activity significantly contribute to disease progression.
  • Optimal glycemic control and antihypertensive therapies, especially renin-angiotensin system blockers, show renoprotective potential.

Conclusions:

  • Diabetic nephropathy arises from a combination of metabolic and hemodynamic derangements.
  • Targeting specific metabolic pathways and managing hypertension are crucial therapeutic strategies.
  • Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists offer significant renoprotection.

More Related Videos

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy05:06

Effects of Mindfulness Training Combined with Tai Chi in Patients with Diabetic Peripheral Neuropathy

Published on: July 14, 2023

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice04:36

An Assay to Detect Protection of the Retinal Vasculature from Diabetes-Related Death in Mice

Published on: January 12, 2024

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...